Quality Control Usage in High-Density Microarrays Reveals Differential Gene Expression Profiles in Ovarian Cancer |
Villegas-Ruiz, Vanessa
(Experimental Oncology Laboratory, Research Department, National Institute of Pediatrics, Institute of Ophthalmology, "Conde de Valenciana")
Moreno, Jose (Research Direction, Juarez Hospital of Mexico) Jacome-Lopez, Karina (Experimental Oncology Laboratory, Research Department, National Institute of Pediatrics, Institute of Ophthalmology, "Conde de Valenciana") Zentella-Dehesa, Alejandro (Medicine Genomic and Environmental Toxicology Department, Biomedical Research Institute, UNAM) Juarez-Mendez, Sergio (Experimental Oncology Laboratory, Research Department, National Institute of Pediatrics, Institute of Ophthalmology, "Conde de Valenciana") |
1 | Burgoon LD, Eckel-Passow JE, Gennings C, et al (2005). Protocols for the assurance of microarray data quality and process control. Nucleic Acids Res, 33, e172. DOI |
2 | Cai SY, Yang T, Chen Y, et al (2015). Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome. J Ovarian Res, 8, 50. DOI |
3 | Chang C, Wang J, Zhao C, et al (2011). Maximizing biomarker discovery by minimizing gene signatures. BMC Genomics, 12 Suppl 5, S6. |
4 | Bicaku E, Xiong Y, Marchion DC, et al (2012). In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival. Br J Cancer, 106, 1967-75. DOI |
5 | Brazma A, Parkinson H, Sarkans U, et al (2003). ArrayExpress--a public repository for microarray gene expression data at the EBI. Nucleic Acids Res, 31, 68-71. DOI |
6 | Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74. DOI |
7 | Dinalankara W, Bravo HC (2015). Gene expression signatures based on variability can robustly predict tumor progression and prognosis. Cancer Inform, 14, 71-81. |
8 | Edgar R, Domrachev M, Lash AE (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res, 30, 207-10. DOI |
9 | Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70. DOI |
10 | Heyn H, Esteller M (2012). DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet, 13, 679-92. DOI |
11 | Juarez-Mendez S, Zentella-Dehesa A, Villegas-Ruiz V, et al (2013). Splice variants of zinc finger protein 695 mRNA associated to ovarian cancer. J Ovarian Res, 6, 61. DOI |
12 | Ma XJ, Dahiya S, Richardson E, et al (2009). Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res, 11, R7. DOI |
13 | McCall MN, Murakami PN, Lukk M, et al (2011). Assessing affymetrix GeneChip microarray quality. BMC Bioinformatics, 12, 137. DOI |
14 | Sun QL, Zhao CP, Wang TY, et al (2015). Expression profile analysis of long non-coding RNA associated with vincristine resistance in colon cancer cells by next-generation sequencing. Gene, 572, 79-86. DOI |
15 | Zakharkin SO, Kim K, Mehta T, et al (2005). Sources of variation in Affymetrix microarray experiments. BMC Bioinformatics, 6, 214. DOI |
16 | Horikawa N, Baba T, Matsumura N, et al (2015). Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients. BMC Cancer, 15, 739. DOI |
17 | Irizarry RA, Bolstad BM, Collin F, et al (2003). Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res, 31, e15. DOI |
18 | Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96. DOI |
19 | Knudsen S, Hother C, Gronbaek K, et al (2015). Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL. PLoS One, 10, e0115538. DOI |
20 | Kolesnikov N, Hastings E, Keays M, et al (2015). ArrayExpress update--simplifying data submissions. Nucleic Acids Res, 43, D1113-6. DOI |
21 | Li MH, Fu SB, Xiao HS (2015). Genome-wide analysis of microRNA and mRNA expression signatures in cancer. Acta Pharmacol Sin, 36, 1200-11. DOI |
22 | Placa JR, Bueno Rde B, Pinheiro DG, et al (2015). Gene expression analysis of laryngeal squamous cell carcinoma. Genom Data, 5, 9-12. DOI |
23 | Panteris E, Swift S, Payne A, et al (2007). Mining pathway signatures from microarray data and relevant biological knowledge. J Biomed Inform, 40, 698-706. DOI |
24 | Parkinson H, Sarkans U, Shojatalab M, et al (2005). ArrayExpress--a public repository for microarray gene expression data at the EBI. Nucleic Acids Res, 33, D553-5. DOI |
25 | Pepper SD, Saunders EK, Edwards LE, et al (2007). The utility of MAS5 expression summary and detection call algorithms. BMC Bioinformatics, 8, 273. DOI |
26 | Quackenbush J (2001). Computational analysis of microarray data. Nat Rev Genet, 2, 418-27. DOI |
27 | Rocca-Serra P, Brazma A, Parkinson H, et al (2003). ArrayExpress: a public database of gene expression data at EBI. C R Biol, 326, 1075-8. DOI |
28 | Rong G, Kang H, Wang Y, et al (2013). Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs). PLoS One, 8, e70960. DOI |
29 | Seo J, Gordish-Dressman H, Hoffman EP (2006). An interactive power analysis tool for microarray hypothesis testing and generation. Bioinformatics, 22, 808-14. DOI |
30 | Sonachalam M, Shen J, Huang H, et al (2012). Systems biology approach to identify gene network signatures for colorectal cancer. Front Genet, 3, 80. |
![]() |